Blood Glucose Monitoring System Market, By Product (Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems, Insulin Drug Delivery Devices), Testing Site (Alternate Site Testing, Fingertip Testing), Connectivity Technology (Biosensors, Bluetooth-Enabled, Smartphone Based Glucometers, Others), Advanced Devices (Smart Contact Lenses, Laser Based System, Earlobe Devices, Saliva Analyzers, Wearables, Others), Patient Care Setting (Hospitals & Clinics, Home Care), Application (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes) Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The global blood glucose monitoring system market is anticipated to reach USD 11.7 billion by 2020 growing at a CAGR of 5.2% during the forecasting period, 2020-2028. Blood glucose monitoring systems are the diagnostic systems that are necessary for the care & treatment of diabetes which is used for measuring and monitoring the levels of blood sugar in patients. Factors such as the growing prevalence of diabetes and the rising number of product launches are some of the major drivers for the market of blood glucose monitoring system
The global blood glucose monitoring system market is segmented into modality products, testing sites, connectivity technology, advanced devices, patient care setting, application, and geography.
The product segment is segmented into self-monitoring blood glucose systems, continuous glucose monitoring systems, insulin drug delivery devices. Self-Monitoring Blood Glucose Systems is further segmented into testing strips, blood glucose meters, lancets & lancing devices. The continuous Glucose Monitoring Systems segment is further segmented into transmitters, sensors, receivers. The Insulin Drug Delivery Devices segment is further segmented into insulin syringes, insulin pens, insulin pumps, insulin jet injectors.
Testing Site segment is segmented into Alternate Site Testing, Fingertip Testing
On the basis of the testing site, the fingertip testing segment is expected to dominate the market for blood glucose monitoring systems during the forecast period 2020-2028
The connectivity technology segment is segmented into Biosensors, Bluetooth-Enabled, Smartphone-Based Glucometers, Others
Advanced devises segment is segmented into Smart Contact Lenses, Laser-Based System, Earlobe Devices, Saliva Analyzers, Wearables, Others
Patient Care Setting segment is segmented into Hospitals & Clinics, Home Care
The application segment is segmented into Type 2 Diabetes, Type 1 Diabetes, and Gestational Diabetes. Type 2 diabetes is further segmented into adults and pediatrics. Type 1 diabetes is further segmented into adults and pediatrics.
Geographically, the global blood glucose monitoring system market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions.
North America region is the largest contributor to the blood glucose monitoring system market in the forecast period 2020-2028.
Key players in global blood glucose monitoring system market F. Hoffmann-LA Roche Ltd, Abbott, Thermo Fisher Scientific Inc., Siemens AG, Bio-Rad Laboratories, Inc., BD, Beckman Coulter, Inc., Biomérieux SA, Cepheid (A Subsidiary Of Danaher Corporation), Enzo Biochem Inc., Grifols International, S.A., Hologic Inc., Immucor, Inc., Meridian Bioscience, Inc., Ortho Clinical Diagnostics among others
The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:
Report Features |
Description |
---|---|
Market Revenue In 2020 |
USD 11.7 billion |
Growth Rate |
CAGR of 5.2% during the forecasting period, 2020-2028 |
Historical Data |
2017-2018 |
Forecast Years |
2020-2028 |
Base Year |
2019 |
Units Considered |
Revenue in USD billion and CAGR from 2020 to 2028 |
Report Segmentation |
Modality Products, Testing Site, Connectivity Technology, Advanced Devices, Patient Care Setting, Application and Geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
F. Hoffmann-LA Roche Ltd, Abbott, Thermo Fisher Scientific Inc., Siemens AG, Bio-Rad Laboratories, Inc., BD, Beckman Coulter, Inc., Biomérieux SA, Cepheid (A Subsidiary Of Danaher Corporation), Enzo Biochem Inc., Grifols International, S.A., Hologic Inc., Immucor, Inc., Meridian Bioscience, Inc., Ortho Clinical Diagnostics among others |
Available Customization |
In addition to the market data for the blood glucose monitoring system market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement. |